Log in to save to my catalogue

Economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the tr...

Economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the tr...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a4213eef89cf41688c752bd952baea4d

Economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from an English National Health Service perspective

About this item

Full title

Economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from an English National Health Service perspective

Publisher

England: British Cardiovascular Society

Journal title

Open heart, 2024-01, Vol.11 (1), p.e002423

Language

English

Formats

Publication information

Publisher

England: British Cardiovascular Society

More information

Scope and Contents

Contents

IntroductionThree recent randomised controlled trials have demonstrated that pulmonary vein isolation as an initial rhythm control strategy with cryoablation reduces atrial arrhythmia recurrence in patients with symptomatic paroxysmal atrial fibrillation (PAF) compared with antiarrhythmic drug (AAD) therapy. The aim of this study was to evaluate th...

Alternative Titles

Full title

Economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from an English National Health Service perspective

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a4213eef89cf41688c752bd952baea4d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a4213eef89cf41688c752bd952baea4d

Other Identifiers

ISSN

2053-3624,2398-595X

E-ISSN

2053-3624

DOI

10.1136/openhrt-2023-002423

How to access this item